Literature DB >> 17410291

Extrahepatic manifestations of chronic HCV infection.

Alessandra Galossi1, Riccardo Guarisco, Lia Bellis, Claudio Puoti.   

Abstract

Several extrahepatic manifestations have been reported in the natural history of hepatitis C virus infection (HCV). Up to 40-74% of patients infected with HCV might develop at least one extrahepatic manifestation during the course of their disease. Mixed Cryoglobulinemia (MC) is the most known and studied syndrome associated with HCV infection. It is a systemic vasculitis that may involve the skin, kidney and nervous system. A frequent reported association is that between HCV infection and non-Hodgkin lymphoma. The cryoglobulinemia may be the intermediary disorder, in fact some persistent forms of cyoglobulinemia can switch over to a more aggressive haematologic disorder. As compared to cutaneous vasculitis described in MC, HCV infection has been associated with dermatological disorders such as porphyria cutanea tarda and lichen planus. Thyroid disease (usually hypothyroidism) is commonly seen in people with HCV. Up to 25% have thyroid antibodies. Several studies described a correlation between HCV and lympho-cytic sialoadenitis, similar to sialoadenitis associated with idiopathic Sjögren syndrome, but we can define as "pseudo- Sjögren syndrome" the one associated with HCV infection, because it shows several differences in the idiopathic form. In the course of chronic HCV infection, a common obser-vation are rheumatological symptoms such as polyarthritis. The clinical pattern of joint involvement in the course of HCV infection varies from a rheumatoid arthritis-like form (very rare), to a non erosive oligoarthritis involving the large-sized and middle joints.

Entities:  

Mesh:

Year:  2007        PMID: 17410291

Source DB:  PubMed          Journal:  J Gastrointestin Liver Dis        ISSN: 1841-8724            Impact factor:   2.008


  49 in total

1.  A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis.

Authors:  Michael C Sneller; Zonghui Hu; Carol A Langford
Journal:  Arthritis Rheum       Date:  2012-03

2.  Expression of microRNA miR-122 facilitates an efficient replication in nonhepatic cells upon infection with hepatitis C virus.

Authors:  Takasuke Fukuhara; Hiroto Kambara; Mai Shiokawa; Chikako Ono; Hiroshi Katoh; Eiji Morita; Daisuke Okuzaki; Yoshihiko Maehara; Kazuhiko Koike; Yoshiharu Matsuura
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

3.  Antibodies to mutated citrullinated vimentin in patients with chronic hepatitis C virus genotype IV infection-related arthropathy.

Authors:  M Zehairy; E Soliman; A Daghaidy
Journal:  Rheumatol Int       Date:  2011-11-09       Impact factor: 2.631

Review 4.  [Hepatitis associated cryoglobulinemia].

Authors:  S Pischke; M Cornberg; M P Manns
Journal:  Internist (Berl)       Date:  2008-03       Impact factor: 0.743

5.  USP15 Participates in Hepatitis C Virus Propagation through Regulation of Viral RNA Translation and Lipid Droplet Formation.

Authors:  Shinji Kusakabe; Tatsuya Suzuki; Yukari Sugiyama; Saori Haga; Kanako Horike; Makoto Tokunaga; Junki Hirano; He Zhang; David Virya Chen; Hanako Ishiga; Yasumasa Komoda; Chikako Ono; Takasuke Fukuhara; Masahiro Yamamoto; Masahito Ikawa; Takashi Satoh; Shizuo Akira; Tomohisa Tanaka; Kohji Moriishi; Moto Fukai; Akinobu Taketomi; Sachiyo Yoshio; Tatsuya Kanto; Tetsuro Suzuki; Toru Okamoto; Yoshiharu Matsuura
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

6.  Characterization of SPP inhibitors suppressing propagation of HCV and protozoa.

Authors:  Junki Hirano; Toru Okamoto; Yukari Sugiyama; Tatsuya Suzuki; Shinji Kusakabe; Makoto Tokunaga; Takasuke Fukuhara; Miwa Sasai; Takahiro Tougan; Yasue Matsunaga; Kazuo Yamashita; Yusuke Sakai; Masahiro Yamamoto; Toshihiro Horii; Daron M Standley; Kohji Moriishi; Kyoji Moriya; Kazuhiko Koike; Yoshiharu Matsuura
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-29       Impact factor: 11.205

Review 7.  Extrahepatic immune related manifestations in chronic hepatitis C virus infection.

Authors:  Maria Tampaki; John Koskinas
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

8.  Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1.

Authors:  Leopold Kong; Erick Giang; Justin B Robbins; Robyn L Stanfield; Dennis R Burton; Ian A Wilson; Mansun Law
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-23       Impact factor: 11.205

9.  Decline of cellular activation in non-B cells after rituximab treatment in hepatitis C-associated mixed cryoglobulinemia vasculitis.

Authors:  B Emmanuel; N Sidique; X Zhang; B Poonia; M C Sneller; S Kottilil
Journal:  J Viral Hepat       Date:  2016-09-25       Impact factor: 3.728

10.  The prevalence of HCV antibodies in skin disease patients in Saudi Arabia.

Authors:  Mona Halawani; Amal Balbisi; Hend Alotaibi; Fahed Alsaif; Talal M Bakir
Journal:  Saudi Pharm J       Date:  2009-12-24       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.